Solid biosciences to participate at upcoming investor conferences

Charlestown, mass., sept. 05, 2023 (globe newswire) -- solid biosciences inc. (nasdaq: sldb), a life sciences company developing genetic medicines for neuromuscular and cardiac diseases, today announced that bo cumbo, president and chief executive officer, will participate in the following two upcoming investor conferences:
SLDB Ratings Summary
SLDB Quant Ranking